Literature DB >> 2129063

Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.

H Hanberger1, L E Nilsson, R Maller, M Nilsson.   

Abstract

The aim of this study was to investigate the pharmacodynamics of beta-lactam antibiotics on Gram-negative bacteria by studying the in vitro postantibiotic effect (PAE), initial killing and morphology. The PAE of aztreonam, cefotaxime, ceftazidime, imipenem, mecillinam and piperacillin on Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Serratia marcescens was studied by use of bioluminescence assay of bacterial ATP. The strains were exposed for 2 h to the beta-lactam antibiotics which were then eliminated by 10(-4) dilution. With E. coli, spheroplasts were seen during incubation with cefotaxime, ceftazidime, imipenem and mecillinam and a long (greater than 1 h) PAE was noted. In contrast, aztreonam and piperacillin produced a short (less than or equal to 1 h) PAE. This was seen concomitantly with the production of filaments and weak initial killing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129063

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  9 in total

Review 1.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring.

Authors:  J M Libby
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.

Authors:  W J Munckhof; D Olden; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae.

Authors:  T K Held; C Adamczik; M Trautmann; A S Cross
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

Review 6.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 7.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

8.  Continuous beta-lactam infusion in critically ill patients: the clinical evidence.

Authors:  Mohd H Abdul-Aziz; Joel M Dulhunty; Rinaldo Bellomo; Jeffrey Lipman; Jason A Roberts
Journal:  Ann Intensive Care       Date:  2012-08-16       Impact factor: 6.925

9.  Interactions among osteoblastic cells, Staphylococcus aureus, and chitosan-immobilized titanium implants in a postoperative coculture system: An in vitro study.

Authors:  Niranjan Ghimire; Berit L Foss; Yuyu Sun; Ying Deng
Journal:  J Biomed Mater Res A       Date:  2015-11-09       Impact factor: 4.854

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.